GO:0006241 CTP biosynthetic process: Nucleotide Synthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006241 (CTP biosynthetic process) describes the de novo enzymatic route that produces cytidine-5'-triphosphate (CTP), the direct precursor for RNA and DNA synthesis.
• The terminal and rate-limiting step is catalyzed by CTP synthase (CTPS1/CTPS2), which converts UTP to CTP using glutamine as the nitrogen donor and ATP for energy.
• CTPS1 and CTPS2 form distinct but interacting complexes; CTPS2 can regulate CTPS1 activity, revealing a previously underappreciated layer of CTP synthase control.
• Structural studies of bifunctional CTP/dCTP synthases have clarified the catalytic architecture that governs pyrimidine nucleotide supply.
• CTP biosynthetic capacity is essential for proliferating cells, and its disruption has been linked to metabolic stress and myocardial glucolipotoxicity models.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are powerful tools for dissecting CTP synthase gene function in health and disease.
Description
CTP biosynthetic process (GO:0006241) is the biological process through which cells synthesize cytidine-5'-triphosphate (CTP) from simpler precursors. CTP is one of the four canonical ribonucleotides required for RNA synthesis and, after reduction to dCTP, for DNA synthesis. Because rapidly dividing cells must maintain a steady supply of CTP, the enzymes that catalyze its production are central to nucleotide metabolism and cell proliferation. The final and committed step in this pathway is catalyzed by CTP synthase, an enzyme that converts UTP to CTP using glutamine as the nitrogen donor and ATP as an energy source. Two human isoforms, CTPS1 and CTPS2, are encoded by distinct genes and can assemble into homo- and heteromeric complexes, with CTPS2 shown to regulate CTPS1 activity. Structural analysis of bifunctional CTP/dCTP synthases has provided detailed insight into how these enzymes coordinate pyrimidine nucleotide supply. Understanding GO:0006241 is therefore fundamental for researchers studying nucleic acid metabolism, cell cycle control, and metabolic stress responses. Experimental models that perturb CTP synthesis, including CRISPR-engineered cell lines, are increasingly used to probe these functions.
CTP biosynthetic process At A Glance
| GO ID | GO:0006241 |
|---|---|
| GO term | CTP biosynthetic process |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Synthesis of CTP from UTP by CTP synthase, supporting RNA and DNA synthesis |
| Key enzymes | CTPS1, CTPS2 |
| Pathway location | Pyrimidine nucleotide biosynthesis |
| Substrates | UTP, glutamine, ATP |
| Product | CTP |
What Is GO:0006241?
CTP biosynthetic process (GO:0006241) is the set of biochemical reactions that result in the formation of cytidine-5'-triphosphate (CTP) from precursor molecules. In the canonical pathway, UTP is aminated to CTP by CTP synthase, which utilizes glutamine as the nitrogen donor and ATP as an energy source. This process is essential for providing the CTP needed for RNA transcription and, following reduction, for DNA replication.
Why Is CTP biosynthetic process Important in Cell Biology?
CTP biosynthetic process is critical because CTP is a rate-limiting substrate for RNA and DNA synthesis, and its production must be tightly coordinated with cell growth and division. Dysregulation of CTP synthase enzymes has been implicated in metabolic stress and disease models, including myocardial glucolipotoxicity. The discovery that CTPS2 regulates CTPS1 activity highlights the complexity of this pathway and its potential as a therapeutic target.
• Provides CTP for RNA transcription and DNA replication.
• Supports proliferating cells that require high nucleotide pools.
• CTPS1 and CTPS2 are distinct genes with non-redundant functions.
• CTPS2 can regulate CTPS1 activity, revealing inter-isoform control.
• Structural insights from bifunctional CTP/dCTP synthases inform drug design.
• CTP synthase is a potential target in metabolic stress and myocardial injury models.
• CRISPR models enable precise dissection of CTP synthase gene function.
• Nucleoside analogue pharmacology intersects with CTP metabolism.
What Happens During CTP biosynthetic process?
Substrate activation and glutamine hydrolysis
In simple terms: The enzyme first prepares its nitrogen donor by breaking down glutamine.
CTP synthase catalyzes the transfer of an amino group from glutamine to UTP. The enzyme first hydrolyzes glutamine to glutamate and ammonia, a step that requires ATP and generates an activated intermediate. This mechanism is conserved across bifunctional CTP/dCTP synthases, as revealed by structural studies.
UTP amination to CTP
In simple terms: The nitrogen from glutamine is attached to UTP to make CTP.
The ammonia generated from glutamine is used to aminate UTP at the C4 position, producing CTP. This is the terminal and committed step of the pathway and is catalyzed by the synthetase domain of CTP synthase. The reaction consumes ATP, which is required for the initial activation of UTP.
Isoform-specific complexes: CTPS1 and CTPS2
In simple terms: Two versions of the enzyme can work together or separately.
Human cells express two CTP synthase isoforms, CTPS1 and CTPS2, which can form homo- and heteromeric complexes. CTPS2 has been shown to interact with CTPS1 and regulate its enzymatic activity, indicating that the CTP biosynthetic process is modulated by isoform composition.
Integration with pyrimidine nucleotide pools
In simple terms: CTP production is balanced with other nucleotide pathways.
CTP synthesized by this process feeds into the broader pyrimidine nucleotide pool and is used for RNA synthesis and, after reduction to dCTP, for DNA synthesis. Structural and biochemical studies of bifunctional CTP/dCTP synthases have illuminated how these enzymes coordinate the supply of CTP and dCTP.
Key Genes Involved in GO:0006241 CTP biosynthetic process
The following genes and proteins are directly implicated in CTP biosynthetic process (GO:0006241) based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CTPS1 | Catalyzes the final step of CTP synthesis from UTP | Isoform-specific regulation and complex formation |
| CTPS2 | Interacts with and regulates CTPS1 activity | Modulator of CTP synthase function |
| CTPS (bifunctional) | Bifunctional CTP/dCTP synthase in some organisms | Structural basis of pyrimidine synthesis |
| UTP | Substrate for CTP synthase | Direct precursor in the reaction |
| Glutamine | Nitrogen donor for UTP amination | Essential co-substrate |
| ATP | Energy source for glutamine hydrolysis and UTP activation | Required cofactor |
| CTP | Product of the pathway | Used for RNA and DNA synthesis |
| dCTP | Product of bifunctional CTP/dCTP synthase | DNA synthesis precursor |
| CTPS1-CTPS2 complex | Heteromeric assembly | Regulatory node in CTP synthesis |
| Glutamate | Byproduct of glutamine hydrolysis | Indicator of enzyme activity |
| Ammonia | Transient intermediate | Nitrogen transfer chemistry |
| CTP synthase (general) | Enzyme family catalyzing CTP formation | Target for metabolic studies |
How Is CTP biosynthetic process Regulated?
CTP biosynthetic process is regulated at multiple levels. The interaction between CTPS1 and CTPS2 provides a direct mechanism for modulating enzyme activity, with CTPS2 capable of regulating CTPS1. Additionally, the pathway is sensitive to metabolic stress, as shown in models of myocardial glucolipotoxicity where CTP-related nanozymes were used to alleviate lipid peroxidation. Nucleoside analogue pharmacology also intersects with CTP metabolism, as these drugs can affect nucleotide pools.
CTP biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CTPS1 | Metabolic stress, myocardial glucolipotoxicity | CRISPR knockout in cardiomyocytes |
| CTPS2 | Cancer cell proliferation | Overexpression and knockout in cancer cell lines |
| CTPS (bifunctional) | Pyrimidine nucleotide imbalance | Structural and biochemical assays |
| CTP synthase | Nucleoside analogue response | Pharmacological studies in cell models |
CTP synthase in metabolic stress and myocardial injury
CTP biosynthetic process has been linked to metabolic stress in the heart. In a model of myocardial glucolipotoxicity, Ru/CoMn-LDH@CTP nanozymes with catalytic antioxidant activity were shown to alleviate glucolipotoxicity through inhibition of lipid peroxidation, suggesting that CTP-related pathways are involved in cardiac metabolic dysfunction. This highlights the potential of targeting CTP metabolism in myocardial infarction and related conditions.
CTP synthase isoforms and cancer metabolism
Rapidly proliferating cancer cells have elevated demand for nucleotides, including CTP. The discovery that CTPS2 regulates CTPS1 activity suggests that isoform-specific targeting could be explored in cancers dependent on CTP synthesis. Structural studies of bifunctional CTP/dCTP synthases provide a foundation for designing inhibitors that could disrupt pyrimidine nucleotide supply in tumors.
Nucleoside analogue pharmacology and CTP metabolism
Nucleoside analogues are widely used in cancer and antiviral therapy, and their clinical pharmacology is closely tied to nucleotide metabolism. Because CTP is a key nucleotide, perturbations in CTP biosynthetic process can influence the efficacy and toxicity of these drugs.
From CTP biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CTPS1 loss impair cell proliferation? | CTPS1 knockout cell line |
| Does CTPS2 regulate CTPS1 activity? | CTPS2 overexpression and knockout |
| What is the catalytic mechanism of CTP synthase? | Point mutations in catalytic residues |
| How does CTP synthase localize in cells? | Tagged knock-in with fluorescent protein |
| Can CTP synthesis be targeted in myocardial stress? | CRISPR knockout in cardiac cell models |
| What is the role of CTPS1-CTPS2 heteromers? | Double knockout and rescue experiments |
How to Study the CTP biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic assay | CTP synthase activity | Validation of CRISPR edits |
| X-ray crystallography | Protein structure | Mechanistic studies |
| CRISPR knockout screen | Gene essentiality | Identifying pathway components |
| Metabolomics | Nucleotide levels | Assessing CTP pool changes |
| Western blot | Protein expression | Confirming knockout or overexpression |
| Co-immunoprecipitation | Protein-protein interactions | Studying CTPS1-CTPS2 complexes |
| Fluorescence microscopy | Subcellular localization | Tagged knock-in models |
Enzymatic assays for CTP synthase activity
Direct measurement of CTP synthase activity can be performed using radiolabeled or HPLC-based assays that monitor the conversion of UTP to CTP. These assays are essential for validating the effects of CRISPR-mediated gene edits on CTP biosynthetic process.
Structural biology and crystallography
X-ray crystallography and cryo-EM have been used to determine the structure of bifunctional CTP/dCTP synthases, revealing the catalytic domains and substrate-binding sites. These methods provide atomic-level insight into the mechanism of CTP formation.
CRISPR screening and functional genomics
CRISPR knockout screens can identify genes required for CTP biosynthetic process and uncover synthetic lethal interactions. Such screens are particularly useful for studying metabolic vulnerabilities in cancer cells.
Metabolomics and nucleotide profiling
Mass spectrometry-based metabolomics allows quantification of CTP and other nucleotides in cells. This approach can reveal how genetic perturbations in CTPS1 or CTPS2 affect the overall pyrimidine pool.
How CRISPR Can Be Used to Study GO:0006241 CTP biosynthetic process
Knockout
CRISPR knockout of CTPS1 or CTPS2 can be used to determine their individual contributions to CTP biosynthetic process. Loss of CTPS1 is expected to reduce CTP synthase activity, while CTPS2 knockout may alter the regulation of CTPS1.
Point Mutation
Point mutations in catalytic residues of CTP synthase can be introduced to dissect the enzymatic mechanism. Such mutations can abolish glutamine hydrolysis or UTP amination, providing insights into the stepwise chemistry of CTP synthesis.
Knock-in
Knock-in of epitope tags or fluorescent proteins allows visualization and purification of CTP synthase complexes. This approach can reveal the subcellular localization and dynamics of CTPS1 and CTPS2.
Overexpression
Overexpression of CTPS1 or CTPS2 can be used to study gain-of-function effects on CTP levels and cell proliferation. Overexpression of CTPS2 may modulate CTPS1 activity, providing a way to test regulatory interactions.
How EDITGENE Supports CTP biosynthetic process Research
Researchers studying CTP biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in CTP production, how specific mutations affect enzyme activity, or whether a gene product interacts with CTPS1 or CTPS2. EDITGENE provides a comprehensive suite of CRISPR services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for CTP biosynthetic process research.
Frequently Asked Questions About CTP biosynthetic process
What is CTP biosynthetic process?
CTP biosynthetic process (GO:0006241) is the metabolic pathway that produces cytidine-5'-triphosphate (CTP) from UTP, primarily through the action of CTP synthase.
What genes are involved in CTP biosynthetic process?
The key genes are CTPS1 and CTPS2, which encode the two isoforms of CTP synthase.
What is the role of CTPS1 in CTP synthesis?
CTPS1 catalyzes the final step of CTP synthesis, converting UTP to CTP using glutamine and ATP.
How does CTPS2 regulate CTP synthase?
CTPS2 interacts with CTPS1 and regulates its enzymatic activity, forming heteromeric complexes.
What diseases are linked to CTP biosynthetic process?
Dysregulation has been implicated in metabolic stress, myocardial glucolipotoxicity, and cancer cell proliferation.
What is the structural basis of CTP synthase?
Structural studies of bifunctional CTP/dCTP synthases have revealed the catalytic domains and substrate-binding sites.
How can CRISPR be used to study CTP biosynthetic process?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of CTPS1 and CTPS2 genes.
What methods measure CTP synthase activity?
Enzymatic assays, metabolomics, and structural biology are commonly used to measure CTP synthase activity.
Is CTP synthase a drug target?
Yes, CTP synthase is considered a potential target in cancer and metabolic diseases due to its role in nucleotide supply.
What is the difference between CTPS1 and CTPS2?
CTPS1 and CTPS2 are distinct isoforms; CTPS2 can regulate CTPS1 activity, and they may have non-redundant functions.
Conclusion
CTP biosynthetic process (GO:0006241) is a fundamental metabolic pathway that supplies CTP for RNA and DNA synthesis. The two CTP synthase isoforms, CTPS1 and CTPS2, are central to this process, with CTPS2 acting as a regulator of CTPS1. Structural insights into bifunctional CTP/dCTP synthases have advanced our understanding of the catalytic mechanism. Dysregulation of this pathway has been linked to metabolic stress and myocardial injury, making it a compelling target for further research. CRISPR-based models offer powerful tools to dissect the roles of CTPS1 and CTPS2 in health and disease.
References
- 1. Zhang S et al.. 2027. Ru/CoMn-LDH@CTP nanozymes with catalytic antioxidant activity alleviate myocardial glucolipotoxicity through inhibition of lipid peroxidation.. Biomaterials 336:124455 PMID: 42462536
- 3. Guo CJ et al.. 2024. Structural Basis of Bifunctional CTP/dCTP Synthase.. J Mol Biol 436(20):168750 PMID: 39173734
- 4. Minet N et al.. 2025. CTPS2 regulates CTP synthetase activity by interacting with CTPS1.. Life Sci Alliance 8(11) PMID: 40957650
- 7. Milano G et al.. 2002. [Clinical pharmacology of nucleoside analogues].. Bull Cancer 89 Spec No:S71-5 PMID: 12449033
